CAM
VIVO

ClariVest Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

ClariVest Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,300
Closed -$638K – 847
2021
Q1 		$638K Buy
24,300
+1,300
+6% +$30.9K 0.02% 373
2020
Q4 		$429K Buy
23,000
+6,900
+43% +$129K 0.01% 407
2020
Q3 		$273K Sell
16,100
-1,100
-6% -$21.4K 0.01% 428
2020
Q2 		$400K Buy
+17,200
New +$249K 0.01% 438

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClariVest Asset Management's VIVO Position: Q2 2021 in Review

ClariVest Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 24,300 shares — an estimated $638K sold.

ClariVest Asset Management first reported a position in VIVO in Q2 2020 and held it in 4 quarters. The position peaked at $638K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • ClariVest Asset Management reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • ClariVest Asset Management sold 24,300 Meridian Bioscience Inc shares in Q2 2021, an estimated $638K.
  • ClariVest Asset Management first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 4 quarters.
  • ClariVest Asset Management's Meridian Bioscience Inc position peaked at $638K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.